4-chloro-4-(2,2,2-trichloroethyl)-oxetan-2-one | 81189-95-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酯类
• 英文名称: 4-chloro-4-(2,2,2-trichloroethyl)-oxetan-2-one
• 英文别名: 4-chloro-4-(2,2,2-trichloromethyl)oxetan-2-one；4-chloro-4-(2,2,2-trichloroethyl)oxetan-2-one；4-chloro-4-(2,2,2,trichloro-ethyl)-oxetan-2-one；4-chloro-4(2,2,2,trichloro-ethyl)-oxetan-2-one
• CAS: 81189-95-9
• 化学式: C₅H₄Cl₄O₂
• 分子量: 237.898
• InChiKey: BVWKKDBTTFIKCM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-chloro-4-(2,2,2-trichloroethyl)-oxetan-2-one 在 四(三苯基膦)钯 高氯酸 、 碳酸氢钠 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 21.33h， 生成 2-Biphenyl-4-yl-6-morpholin-4-yl-pyran-4-one
  参考文献：
  名称：

  Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase

  摘要：

  Structure-activity relationships have been investigated for inhibition of DNA-dependent protein kinase (DNA-PK) and ATM kinase by a series of pyran-2-ones, pyran-4-ones, thiopyran-4-ones, and pyridin-4-ones. A wide range of IC50 values were observed for pyranones and thiopyranones substituted at the 6-position, with the 3- and 5-positions proving intolerant to substitution. Related pyran-2-ones, pyran-4-ones, and thiopyran-4-ones showed similar IC50 values against DNA-PK, whereas the pyridin-4-one system proved, in general, ineffective at inhibiting DNA-PK. Extended libraries exploring the 6-position of 2-morpholino-pyran-4-ones and 2-morpholino-thiopyrano-4-ones identified the first highly potent and selective ATM inhibitor 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (151C; ATM; IC50 = 13 nM) and revealed constrained SARs for ATM inhibition compared with DNA-PK. One of the most potent DNA-PK inhibitors identified, 2-(4-methoxyphenyl)-6-(morpholin-4-yl)pyran-4-one (16; DNA-PK; IC50 = 220 nM) effectively sensitized HeLa cells to the topoisomerase II inhibitor etoposide in vitro.

  DOI：

  10.1021/jm061121y
• 作为产物：
  描述：

  双乙烯酮 、 四氯化碳 在 双(4-叔丁基环己基)过氧化二碳酸酯 作用下， 反应 3.0h， 以52.9%的产率得到4-chloro-4-(2,2,2-trichloroethyl)-oxetan-2-one
  参考文献：
  名称：

  ATM inhibitors

  摘要：

  该应用涉及一种具有以下式I的化合物：其中P和Q中的一个是O，另一个是CH，Q和P中的CH之一之间存在双键，并且带有R3基团的碳原子；Y可以是O或S；R1和R2独立地是氢、可选择地取代的C1-7烷基、C3-20杂环基团或C5-20芳基，或者可以一起形成具有4至8个环原子的可选择地取代的杂环环；R3是苯基或吡啶基团，通过第一桥基团连接到一个可选择地取代的C5-20碳芳基团，该苯基或吡啶基团和可选择地取代的C5-20碳芳基团可以进一步通过第二桥基团连接，从而形成一个可选择地取代的C5-7环，苯基或吡啶基团可以进一步选择性地取代。

  公开号：

  US20040002492A1

文献信息

• [EN] AMINOPYRONES AND THEIR USE AS ATM INHIBITORS<br/>[FR] AMINOPYRONES ET LEUR UTILISATION EN TANT QU'INHIBITEURS D'ATM
  申请人：KUDOS PHARM LTD

  公开号：WO2005016919A1

  公开（公告）日：2005-02-24

  Compounds of formula (I) wherein R1 and R2 together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring, X is S, NR’’ or CH2, R and R’ are hydrogen or specified substituents, and R’’ is a specified substituent, are useful as inhibitors of the kinase ATM (ataxia-telangiectasia mutated), particularly in the treatment of cancer and retroviral mediated diseases.

  具有式（I）的化合物，其中R1和R2与它们连接的氮原子一起形成一个可选择取代的杂环环，X为S、NR’’或CH2，R和R’为氢或指定的取代基，R’’为一个指定的取代基，可用作激酶ATM（共济失调-毛细血管扩张性疾病突变）的抑制剂，特别是在癌症和逆转录病原体介导的疾病的治疗中。
• Process for 4,6-di-substituted 2-aminopyrimidines
  申请人：Ciba-Geigy Corporation

  公开号：US04723006A1

  公开（公告）日：1988-02-02

  New compounds useful as intermediates for biologically-active compounds have the formula I ##STR1## wherein Y is a group having the formula --CH.sub.2 X in which X is F, Cl, or Br, or Y is a group having the formula ##STR2## in which R.sup.2 is F, Cl or Br and R.sup.3 is H, F, Cl, Br or a group having the formula --CR.sup.4 R.sup.5 R.sup.6, in which R.sup.4, R.sup.5 and R.sup.6, independently, are F, Cl or Br; A is H, OH, SH, F, Cl, Br or a group --OR.sup.7 or --SR.sup.7 in which R.sup.7 is C.sub.1 -C.sub.4 straight- or branched chain alkyl, C.sub.2-4 straight- or branched chain alkyl substituted with 1 to 3 F, Cl or Br atoms, or A is a group --NR.sup.8 R.sup.9 in which R.sup.8 and R.sup.9, independently, are H, C.sub.1 -C.sub.4 straight- or branched chain alkyl or C.sub.3 -C.sub.4 alkenyl, or R.sup.8 and R.sup.9 together may form a C.sub.3 -C.sub.7 polymethylene chain, which is optionally interrupted by an oxygen atom; as well as salts of compounds of formula I with acids; provided that: when Y is CH.sub.2 F, then A is as hereinbefore defined other than OH, Cl or OCH.sub.3.

  新化合物可用作生物活性化合物的中间体，其化学式为I ##STR1## 其中Y是具有公式--CH.sub.2 X的基团，其中X是F、Cl或Br，或Y是具有公式##STR2##的基团，其中R.sup.2是F、Cl或Br，而R.sup.3是H、F、Cl、Br或具有公式--CR.sup.4 R.sup.5 R.sup.6的基团，其中R.sup.4、R.sup.5和R.sup.6独立地是F、Cl或Br；A是H、OH、SH、F、Cl、Br或--OR.sup.7或--SR.sup.7的基团，其中R.sup.7是C.sub.1-C.sub.4直链或支链烷基、C.sub.2-4直链或支链烷基，其上有1至3个F、Cl或Br原子取代，或A是--NR.sup.8 R.sup.9的基团，其中R.sup.8和R.sup.9独立地是H、C.sub.1-C.sub.4直链或支链烷基或C.sub.3-C.sub.4烯基，或R.sup.8和R.sup.9共同形成C.sub.3-C.sub.7聚亚甲基链，该链可以被氧原子打断；以及化合物I与酸的盐；但是，当Y为CH.sub.2 F时，A的定义如上所述，但不包括OH、Cl或OCH.sub.3。
• [EN] PYRANONES USEFUL AS ATM INHIBITORS<br/>[FR] PYRANONES UTILES COMME INHIBITEURS DE L'ATM
  申请人：KUDOS PHARM LTD

  公开号：WO2003070726A1

  公开（公告）日：2003-08-28

  The application concerns a compound of formula I: (I) wherein one of P and Q is O, and the other of P and Q is H, where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R3 group;Y is either O or S;R1 and R2 are independently hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form an optionally substituted heterocyclic ring having from 4 to 8 ring atoms;R3 is a phenyl or pyridyl group, attached by a first bridge group selected from -S-, -S (=O)-, -S(=O)2-, -O-, -NRN- and CRC1RC2- to an optionally substituted C5-20 carboaryl group, the phenyl or pyridyl group and optionally substituted C5-20 carboaryl group being optionally further linked by a second bridge group, so as to form an optionally substituted C5-7 ring, the phenyl or pyridyl group being further optionally substituted.

  该应用涉及一种具有化学式I的化合物：（I）其中P和Q中的一个是O，另一个是H，在Q和P中的哪一个是CH和带有R3基团的碳原子之间存在双键；Y可以是O或S；R1和R2独立地是氢，可选的取代C1-7烷基，C3-20杂环基团或C5-20芳基团，或者可以共同形成具有4至8个环原子的可选取代杂环环；R3是连接到可选取代的C5-20碳基芳基基团的苯基或吡啶基团，该苯基或吡啶基团通过第一桥基团（选自-S-，-S（=O）-，-S（=O）2-，-O-，-NRN-和CRC1RC2-）连接，苯基或吡啶基团和可选取代的C5-20碳基芳基基团可以通过第二桥基团进一步连接，以形成可选取代的C5-7环，苯基或吡啶基团可以进一步取代。
• [EN] DNA-PK INHIBITORS<br/>[FR] INHIBITEURS D'ADN-PK
  申请人：CANCER REC TECH LTD

  公开号：WO2003024949A1

  公开（公告）日：2003-03-27

  The invention relates to the use of compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, in the preparation of a medicament for inhibiting the activity of DNA-PK, wherein R?1 and R2¿ are independently hydrogen, an optionally substituted C¿1-7? alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; X and Y are selected from CR?4¿ and O, O and CR'4 and NR'4 and N, where the unsaturation is in the appropriate place in the ring, and where one of R?3 and R4 or R'4¿ is an optionally substituted C¿3-20? heteroaryl or C5-20 aryl group, and the other of R?3 and R4 or R'4¿ is H, or R?3 and R4 or R'4¿ together are -A-B-, which collectively represent a fused optionally substituted aromatic ring. The compounds also selectively inhibit the activity of DNA-PK compared to PI 3-kinase and/or ATM.

  本发明涉及使用式(I)化合物及其异构体、盐、溶剂合物、化学保护形式和前药，在制备用于抑制DNA-PK活性的药物中使用，其中R?1和R2¿分别为氢、可选取代的C¿1-7?烷基、C3-20杂环基或C5-20芳基，或者可以与它们连接的氮原子一起形成具有4到8个环原子的可选取代杂环环；X和Y从CR?4¿和O、O和CR'4和NR'4和N中选取，其中不饱和度在环中适当位置，其中R?3和R4或R'4¿中的一个为可选取代的C¿3-20?杂芳基或C5-20芳基，而另一个为H，或者R?3和R4或R'4¿一起是-A-B-，它们共同代表一个融合的可选取代芳香环。这些化合物还比PI 3-激酶和/或ATM选择性地抑制DNA-PK活性。
• Dna-pk inhibitors
  申请人：——

  公开号：US20040192687A1

  公开（公告）日：2004-09-30

  The invention relates to the use of compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, in the preparation of a medicament for inhibiting the activity of DNA-PK, wherein R 1 and R 2 are independently hydrogen, an optionally substituted C 1-7 alkyl group, C 3-20 heterocyclyl group, or C 5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; X and Y are selected from CR 4 and O, O and CR′ 4 and NR″ 4 and N, where the unsaturation is in the appropriate place in the ring, and where one of R 3 and R 4 or R′ 4 is an optionally substituted C 3-20 heteroaryl or C 5-20 aryl group, and the other of R 3 and R 4 or R′ 4 is H, or R 3 and R 4 or R″ 4 together are —A—B—, which collectively represent a fused optionally substituted aromatic ring. The compounds also selectively inhibit the activity of DNA-PK compared to PI 3-kinase and/or ATM. 1

  本发明涉及使用式(I)化合物及其异构体、盐、溶剂合物、化学保护形式及其前药，在制备抑制DNA-PK活性的药物方面使用。其中，R1和R2分别为氢、可选取代的C1-7烷基、C3-20杂环基或C5-20芳基，或者与它们连接的氮原子一起形成含有4到8个环原子的可选取代杂环环；X和Y从CR4和O、O和CR'4以及NR"4和N中选择，其中不饱和度在环中适当位置，且R3和R4或R'4中的一个为可选取代的C3-20杂芳基或C5-20芳基，而另一个为氢，或者R3和R4或R"4一起为-A-B-，它们共同表示一个融合的可选取代芳香环。这些化合物与PI 3-激酶和/或ATM相比，也具有选择性抑制DNA-PK活性的作用。